TMCnet News
16.3% Return Seen to Date on SmarTrend Celgene Call (CELG)Jan 09, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on November 23rd, 2012 at $78.14. In approximately 2 months, Celgene has returned 16.33% as of today's recent price of $90.90. Over the past year, Celgene has traded in a range of $58.53 to $91.71 and is now at $90.90, 55% above that low. The 200-day and 50-day moving averages have moved 0.22% higher and 0.91% higher over the past week, respectively. Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Celgene shares.Log in and add Celgene (CELG) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |